Medical News

RSS

Computationally designed antiviral proteins may fight against influenza

A research article May 12 in Science demonstrates the use of computational methods to design new antiviral proteins not found in nature, but capable of targeting specific surfaces of flu virus molecules.

16 May 2011

Bedside screening tool can help diagnose acute aortic dissection

The most lethal and sudden cardiovascular event can be the toughest for doctors to diagnose. But a study by the University of Michigan Cardiovascular Center shows new guidelines are effective for determining who's most likely suffering from an aortic dissection, which is tearing in the lining of the body's largest blood vessel.

16 May 2011

Japan quake, tsunami transform country into major aid recipient

"Until a few months ago Japan was the world's fifth biggest aid donor, according to the Organisation for Economic Co-operation and Development, lending or giving away $9.5bn a year," the Guardian reports. But the recent earthquake and tsunami have transformed the country "into a leading destination for international charity. In two months it has received what the Democratic Republic of the Congo is given in a year," according to the article.

16 May 2011

First fetoscopic laser procedure to correct Twin-Twin Transfusion syndrome performed in Dallas

Jessica and Chad Browning were ecstatic last fall when they learned they were expecting twins. They had two children already, but wanted a third to round out their family. Twins were a bonus.

16 May 2011

Bonn researchers to develop new blood test for lung cancer diagnosis

A person's blood reveals whether he or she has lung cancer: this has been demonstrated by researchers at the University of Bonn. In collaboration with colleagues at the Cologne University Hospital, they are developing a blood test for smokers which could save human lives in the future, since the earlier a lung tumor is detected, the better the chances of survival are.

16 May 2011

Synexus completes CT327 phase II psoriasis trial for Creabilis

Synexus has completed a phase II study for the European biotech, Creabilis, recruiting 26 patients in the UK to the psoriasis trial of its CT327 lead product in just 2 weeks, as part of an international proof-of-concept study. The company delivered the targeted number of patients well within the agreed timelines and budget.

From AES - Accelerated Enrollment Solutions 16 May 2011

Counterfeit medicines posing increasing risk to patients worldwide, U.N. agency says

Counterfeit medications are posing an increasing threat to patients' health worldwide, because they offer high returns and low risks for criminal organizations, the U.N. Office on Drugs and Crime said in a statement on Friday, Agence France-Presse reports.

16 May 2011

Simple, minimal invasive technique could help detect early-stage lung cancer

A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest - and most treatable - stages, according to a study conducted by researchers in Boston.

16 May 2011

New lenalidomide phase III study data presented at 13th International Myeloma Workshop

Updated data from a National Cancer Institute-sponsored clinical trial conducted by the Cancer and Leukemia Group (CALGB) was presented May 5 at the 13th International Myeloma Workshop in Paris, France.

16 May 2011

NewGene develops breakthrough test for hereditary breast cancer

A new breakthrough test for hereditary breast cancer developed by UK-based NewGene could see thousands of women being diagnosed with the genetic condition in around half the usual time and at around half the cost of conventional test methods.

16 May 2011

Report calls for developing new methods of contraception for women in developing countries

Women in the developing world need new methods of contraception that meet their needs and lifestyles, according to a Guttmacher Institute report that urges more investment in contraceptive technology, Agence France-Presse reports.

16 May 2011

New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20, 2011

Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.

16 May 2011

Study reveals role of KLF14 regulatory gene in type 2 diabetes

A team of researchers, led by King's College London and the University of Oxford, have found that a gene linked to type 2 diabetes and cholesterol levels is in fact a 'master regulator' gene, which controls the behaviour of other genes found within fat in the body.

16 May 2011

Karo Bio symposium to discuss research on ER-beta and therapeutic applications

Karo Bio AB is organizing a symposium in Stockholm on May 16-17, where key researchers from the industry and the academic community present and discuss the frontier of research in the field of estrogen receptor beta (ER-beta) and its therapeutic applications.

16 May 2011

Global health Product Development Partners consortium select GVK BIO as preferred provider

GVK Biosciences, Asia's leading drug discovery research & development organization announced today that it has been selected as a preferred provider to a consortium of 14 global Product Development Partners (PDPs) for clinical services in Asia. GVK BIO is the only partner that is headquartered in India.

16 May 2011

Romney's defense of Massachusetts health plan triggers political questions

In what was billed as a major health care speech, Mitt Romney defended his state's plan but distanced himself from the federal health law, despite many similarities to the law Mitt Romney signed while governor. The circumstances have him walking a political tightrope.

16 May 2011

Pre-existing malaria prevents secondary infection by another Plasmodium strain

A team of researchers have found that pre-existing malaria prevents secondary infection by another Plasmodium strain, the parasite responsible for malaria, by restricting iron availability in the liver of the host.

16 May 2011

Study to examine population rates of ED use for adults with intellectual and developmental disabilities

In the first North American study to examine population rates of Emergency Department (ED) use for adults with intellectual and developmental disabilities (IDD), researchers from the Institute for Clinical Evaluative Sciences (ICES) and the Centre for Addiction and Mental Health (CAMH) found 55 per cent of adults with IDD and mental illness visited the ED at least once in a 2 year period and 15.6 per cent visited at least 5 times.

16 May 2011

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

Preliminary results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday " in what is being hailed as a breakthrough in HIV prevention," the Los Angeles Times reports.

16 May 2011

Scientists discover single neuron that enables adaptive regulation of sparseness in olfactory codes

The brain is a coding machine: it translates physical inputs from the world into visual, olfactory, auditory, tactile perceptions via the mysterious language of its nerve cells and the networks which they form. Neural codes could in principle take many forms, but in regions forming bottlenecks for information flow or in areas important for memory, sparse codes are highly desirable.

16 May 2011

Medical News

Computationally designed antiviral proteins may fight against influenza

Bedside screening tool can help diagnose acute aortic dissection

Japan quake, tsunami transform country into major aid recipient

First fetoscopic laser procedure to correct Twin-Twin Transfusion syndrome performed in Dallas

Bonn researchers to develop new blood test for lung cancer diagnosis

Synexus completes CT327 phase II psoriasis trial for Creabilis

Counterfeit medicines posing increasing risk to patients worldwide, U.N. agency says

Simple, minimal invasive technique could help detect early-stage lung cancer

New lenalidomide phase III study data presented at 13th International Myeloma Workshop

NewGene develops breakthrough test for hereditary breast cancer

Report calls for developing new methods of contraception for women in developing countries

New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20, 2011

Study reveals role of KLF14 regulatory gene in type 2 diabetes

Karo Bio symposium to discuss research on ER-beta and therapeutic applications

Global health Product Development Partners consortium select GVK BIO as preferred provider

Romney's defense of Massachusetts health plan triggers political questions

Pre-existing malaria prevents secondary infection by another Plasmodium strain

Study to examine population rates of ED use for adults with intellectual and developmental disabilities

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

Scientists discover single neuron that enables adaptive regulation of sparseness in olfactory codes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News